×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
ON DEMAND - Subscription Models to Incentive Antimicrobial Innovation
Session Chair(s)
Monika Schneider, PhD
Director, Global Antimicrobial Resistance Policy
Shionogi Inc., United States
Population-based reimbursement for antibiotics will potentially support appropriate use while rewarding their societal benefit, but valuation will be key to success. This session will examine factors contributing to value in a subscription model.
Learning Objective : Discuss positive externalities that impact a medical product’s value; Describe challenges to reimbursement based on population health benefits; Assess clinical outcome measures that could contribute to value determinations over time.
Speaker(s)
Panelist
Christine Årdal, PhD, MBA
Norwegian Institute of Public Health, Norway
Senior Advisor
Panelist
Kevin Ronneberg, MD
Health Partners, United States
Vice President and Medical Director, Health Initiatives
To be determined
Patrick Holmes, MS
Pfizer Inc, United States
Innovation Policy Team Lead
Have an account?